Table 1 Demographic and clinical characteristics of participants with overactive bladder using no treatment drugs before each observation period
From: Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder
Characteristics | Pre-Campaign Yeara | Year 1a | Year 2a | p-valueb |
|---|---|---|---|---|
Sample size, n | 1332 | 1277 | 1157 | |
Sex, female, n (%) | 768 (58) | 731 (57) | 666 (58) | .98 |
Age, mean (SD) | 53 (13.1) | 54 (13.2) | 55 (13.5) | .008 |
Comorbidity, n (%)c | ||||
0 | 416 (31) | 337 (26) | 271 (23) | <.001 |
1 | 370 (28) | 364 (29) | 326 (28) | |
≥ 2 | 546 (41) | 576 (45) | 560 (48) | |